📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup. (2019)

First Author: Lancia C

Attributed to: Analysis of trials, meta-analyses and observational studies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00280-019-03797-3

PubMed Identifier: 30879111

Publication URI: http://europepmc.org/abstract/MED/30879111

Type: Journal Article/Review

Volume: 83

Parent Publication: Cancer chemotherapy and pharmacology

Issue: 5

ISSN: 0344-5704